Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Treatment of Diabetic Foot Ulcers: Application and...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Diabetology

Background:

• Diabetic foot ulcers (DFU) are a severe complication of diabetes mellitus, characterized by chronic wounds and microvascular obstruction.
• Current treatments for DFU are often ineffective, leading to slow healing and persistent issues.
• Mesenchymal stromal cells (MSCs) have demonstrated therapeutic potential in preclinical models for diabetes-related complications.

Purpose of the Study:

• To review the therapeutic potential of MSC-derived extracellular vesicles (MSC-EVs) for treating diabetic foot ulcers and lower limb ischemia.
• To explore the mechanisms by which MSC-EVs regulate impaired diabetic wound healing.
• To highlight MSC-EVs as a potential cell-centered therapeutic strategy for DFU.

Main Methods:

• Review of existing literature on MSCs, MSC-EVs, and their effects on diabetic wound healing.
• Analysis of the immunomodulatory and angiogenic properties of MSC-EVs.
• Investigation of the molecular components within MSC-EVs, such as cytokines, growth factors, and nucleic acids.

Main Results:

• MSC-EVs possess significant immunomodulatory and regenerative effects, contributing to accelerated wound closure.
• MSC-EVs promote epithelialization, granulation tissue formation, and angiogenesis in diabetic wound models.
• The paracrine actions and cargo (mRNA, proteins, microRNAs) of MSC-EVs are key to their therapeutic benefits.

Conclusions:

• MSC-derived extracellular vesicles represent a promising cell-free therapeutic approach for diabetic foot ulcers.
• Understanding the mechanisms of MSC-EVs in diabetic wound healing can guide future therapeutic development.
• MSC-EVs offer a novel strategy for managing diabetes-induced lower limb ischemia and ulcers.